A Study to Investigate the Safety and Pharmacokinetic/Pharmacodynamic Characteristics of HSG4112

NCT04703764 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: HSG4112
DRUG: Placebo

Sponsor

Glaceum

Collaborators

[object Object]
[object Object]